Fat redistribution and adipocyte transformation in uninephrectomized rats

Hai-Lu Zhao1, Yi Sui, Jing Guan

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. zhaohailu@yahoo.com

Insights

Chronic kidney dysfunction causes fat redistribution and lipid damage in rats. Angiotensin-converting enzyme (ACE) inhibitor lisinopril treatment prevented these harmful effects, suggesting ACE inhibition may protect against kidney disease-related fat anomalies.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Dyslipidemia significantly impacts renal function and homeostasis.
  • Chronic renal dysfunction can lead to detrimental alterations in fat metabolism and distribution.
  • Lipid peroxidation is a key pathological process in chronic diseases.

Purpose of the Study:

  • To investigate the effects of chronic renal dysfunction on fat redistribution and lipid peroxidation.
  • To evaluate the protective role of angiotensin-converting enzyme (ACE) inhibitor lisinopril in uninephrectomized rats.
  • To understand the impact of ACE inhibition on lipid metabolism in the context of chronic kidney disease.

Main Methods:

  • Induction of chronic renal dysfunction via uninephrectomy in rats.
  • Treatment with lisinopril, an ACE inhibitor, for up to 10 months.
  • Assessment of fat redistribution, adipocyte morphology, and lipid peroxidation markers.

Main Results:

  • Uninephrectomized rats exhibited significant fat redistribution and hypercholesterolemia.
  • A shift from unilocular to multilocular adipocytes and increased ectopic fat accumulation was observed in untreated rats.
  • Lisinopril treatment effectively prevented fat redistribution, adipocyte transformation, and lipid peroxidation.

Conclusions:

  • Chronic renal dysfunction induces significant fat anomalies, including redistribution and lipid peroxidation.
  • ACE inhibition with lisinopril demonstrates a protective effect against these fat-related complications.
  • ACE inhibition may serve as a therapeutic strategy to mitigate metabolic disturbances in chronic kidney disease.

Related Concept Videos